TWiV 988: Clinical update with Dr. Daniel Griffin

In his weekly clinical update Dr. Griffin discusses FDA authorizing the first over-the-counter at-home test to detect both influenza and COVID-19, monoclonal antibody for the prevention of respiratory syncytial virus infection in infants and children, epidemiologic characteristics of SARS-CoV-2 recombinant variant XBB.1.5, COVID-19 vaccines vs pediatric hospitalization, maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life, immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children, fatal fulminant cerebral edema in six children with SARS-CoV-2 Omicron BA.2 infection in Taiwan, certifying deaths due to COVID-19, efficacy of first dose of COVID-19 vaccine vs no vaccination on symptoms of patients with long COVID, and the effect of COVID-19 vaccination on long COVID. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode FDA authorizes over-the-counter at-home test to detect both Influenza and COVID-19 (FDA) Monoclonal antibody for the prevention of RSV in infants and children (JAMA) Epidemiologic characteristics of SARS-CoV-2 variant XBB.1.5 (CDC) COVID-19 vaccines vs pediatric hospitalization (Cell) Maternal SARS-CoV-2 vaccination and infant protection during the first six months of life (Nature) Immunoglobulin, glucocorticoid, or combination therapy for MIS in children (The Lancet) Fatal Fulminant Cerebral Edem...
Source: This Week in Virology - MP3 Edition - Category: Virology Authors: Source Type: podcasts